Anixa Biosciences, Inc. (ANIX)

Anixa Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 29, 2026	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Market Capitalization	104	136	113	98	172	143
Market Cap Growth	43.83%	20.70%	14.71%	-42.82%	20.19%	191.52%
Enterprise Value	86	119	91	72	139	106
Last Close Price	3.03	4.13	3.50	3.16	5.60	4.77
PS Ratio	-	-	-	467.53	-	279.02
PB Ratio	6.60	9.74	5.96	4.20	6.09	4.11
P/TBV Ratio	6.67	8.97	5.63	4.03	5.91	4.03
EV/Sales Ratio	-	-	-	342.38	-	206.32
Debt / Equity Ratio	0.02	0.02	0.01	0.01	0.01	0.01
Asset Turnover	-	-	-	0.01	-	0.02
Quick Ratio	7.71	7.71	8.04	11.89	14.60	28.13
Current Ratio	8.08	8.08	8.55	12.50	14.83	28.35
Return on Equity (ROE)	-67.17%	-67.17%	-60.10%	-38.51%	-43.74%	-61.02%
Return on Assets (ROA)	-38.83%	-38.83%	-36.70%	-24.61%	-26.02%	-35.92%
Return on Capital Employed (ROCE)	-82.90%	-82.90%	-72.40%	-46.90%	-48.90%	-37.50%
Earnings Yield	-10.80%	-8.04%	-11.15%	-9.99%	-7.92%	-9.07%
FCF Yield	-7.09%	-5.28%	-6.51%	-6.32%	-3.78%	-3.46%
Buyback Yield / Dilution	-1.74%	-1.74%	-2.96%	-1.99%	-6.28%	-28.57%

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q